You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

292 Results
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Drugs Used:
lenalidomide (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
May 2022
Blog post
What do you do when you're interested in medicine but can’t handle blood and guts? For Andrea Crespo, the answer was to become a pharmacist. Crespo's...
Apr 2018
Document
Apr 2018
Document
Apr 2018
Blog post
In honour of Patient Experience Week, CCO patient advisor Deb K. shares her thoughts on how healthcare providers can communicate more effectively...
Apr 2018
Document
May 2018
Document
Jun 2018
Document
Jul 2018
Blog post
Passionate. Committed. Patient-focused. These are just a few of the words that have been used to describe this year’s Human Touch Award recipients in...
Sep 2018
Document
Sep 2018
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    ribociclib - For the treatment of patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER 2)-negative, unresectable locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant according to clinical criteria
ODB - General Benefit
    letrozole
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
letrozole,
ribociclib
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Apr 2021

Pages